Cargando…

Supporting the gastrointestinal microenvironment during high-dose chemotherapy and stem cell transplantation by inhibiting IL-1 signaling with anakinra

High-dose chemotherapy causes intestinal inflammation and subsequent breakdown of the mucosal barrier, permitting translocation of enteric pathogens, clinically manifesting as fever. Antibiotics are mainstay for controlling these complications, however, they are increasingly recognized for their det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wardill, H. R., de Mooij, C. E. M., Da Silva Ferreira, A. R., Havinga, H., Harmsen, H. J. M., van der Velden, W. J. F. M., van Groningen, L. F. J., Tissing, W. J. E., Blijlevens, N. M. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095632/ https://www.ncbi.nlm.nih.gov/pubmed/35546555 http://dx.doi.org/10.1038/s41598-022-10700-3

Ejemplares similares

Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever
por: Wardill, H. R., et al.
Publicado: (2021)

Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis
por: Wardill, H. R., et al.
Publicado: (2020)

Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis
por: da Silva Ferreira, Ana Rita, et al.
Publicado: (2020)

Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial
por: de Mooij, Charlotte E. M., et al.
Publicado: (2020)

Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositis
por: da Silva Ferreira, Ana R., et al.
Publicado: (2020)

Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?
por: da Silva Ferreira, Ana Rita, et al.
Publicado: (2021)

Biomarkers and non-invasive tests for gastrointestinal mucositis
por: Kuiken, N. S. S., et al.
Publicado: (2017)

Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy
por: Wardill, Hannah R., et al.
Publicado: (2023)

Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model
por: Kuiken, Nicoline S. S., et al.
Publicado: (2015)

Development of a self-limiting model of methotrexate-induced mucositis reinforces butyrate as a potential therapy
por: da Silva Ferreira, A. R., et al.
Publicado: (2021)

Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study
por: Märtson, Anne-Grete, et al.
Publicado: (2023)

The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
por: van Vliet, Michel J., et al.
Publicado: (2010)

Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation
por: de Kort, Elizabeth A., et al.
Publicado: (2019)

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
por: Ragamin, Aviël, et al.
Publicado: (2023)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole
por: Vreugdenhil, Bas, et al.
Publicado: (2018)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis
por: Gorelik, M., et al.
Publicado: (2019)

Mullins’ syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra
por: Longhurst, H.J., et al.
Publicado: (2015)

A novel mutation in NLRC4 in a large pedigree with an anakinra responsive autoinflammatory disease
por: Volker-Touw, N, et al.
Publicado: (2015)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Host Impairments in Patients with Neoplastic Diseases
por: Donnelly, J. Peter, et al.
Publicado: (2014)

A pilot study of IL-1 inhibition by anakinra in acute gout
por: So, Alexander, et al.
Publicado: (2007)

Mucositis and Infection in Hematology Patients
por: Blijlevens, Nicole M. A., et al.
Publicado: (2023)

Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes
por: Evans, Lucy P., et al.
Publicado: (2020)

Feeding strategies in pediatric cancer patients with gastrointestinal mucositis: a multicenter prospective observational study and international survey
por: Kuiken, Nicoline S.S., et al.
Publicado: (2017)

Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)

The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer
por: de la Court, J. R., et al.
Publicado: (2022)

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell Transplantation
por: van der Velden, Walter J. F. M., et al.
Publicado: (2010)

Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia
por: van der Galiën, Hilde T., et al.
Publicado: (2018)

Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis
por: Crame, Elise E., et al.
Publicado: (2022)

PW02-011 - Favorable response to anakinra in aisle patients
por: Ozdogan, H, et al.
Publicado: (2013)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment
por: Roerink, Megan E., et al.
Publicado: (2017)

Decreased Levels of Circulating IL17-Producing CD161(+)CCR6(+) T Cells Are Associated with Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
por: van der Waart, Anniek B., et al.
Publicado: (2012)

Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra
por: Golino, Michele, et al.
Publicado: (2023)

Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)
por: Cro, S., et al.
Publicado: (2021)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_163jnh4d9219p0crh4oh5keap6